Melita Tate
Internal Medicine · Tulsa, OKNPI 1740289966
Payments from drug & device makers
Across 4,385 payments — averaging $2086.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$7.9M
- Eli Lilly$609K
- AstraZeneca$393K
- Evofem Biosciences, Inc.$110K
- H. Lundbeck A S$82K
- Swing Therapeutics, Inc.$12K
- plus $3K from 8 others
Across 1 payment — averaging $2203.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 4,264 | $7,939,270 |
| Eli Lilly | 7 | $608,815 |
| AstraZeneca | 6 | $392,916 |
| Evofem Biosciences, Inc. | 62 | $110,306 |
| H. Lundbeck A S | 27 | $82,105 |
| Swing Therapeutics, Inc. | 8 | $11,818 |
| Abbott | 1 | $2,616 |
| Novo Nordisk | 2 | $41 |
| Alkermes, Inc. | 2 | $41 |
| Acella Pharmaceuticals, LLC | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
| Amgen | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
How this compares
$9,148,027 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Tulsa
- Al-Ola AbdallahTulsa$10.1M
- Renae MayerTulsa$766K
- Mousumi SomTulsa$391K
- Jesse RichardsTulsa$279K
- Madhuri LadTulsa$195K
- Lam leTulsa$191K
- Stacy ChronisterTulsa$163K
- Katherine CookTulsa$41K
- Layth Al AttarTulsa$35K
- Gerard McNultyTulsa$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.